REZUROCK is definitely an inhibitor of UGT1A1. Coadministration of REZUROCK by using a UGT1A1 substrate diminished plasma concentrations of your glucuronide metabolite, which may raise the danger of adverse reactions connected with delicate substrates of UGT1A1Our medical and scientific workforce continues research to improve therapies and offer yo